Identification of genomic groups in the genus Stenotrophomonas using gyrB RFLP analysis

被引:28
作者
Coenye, T
Vanlaere, E
LiPuma, JJ
Vandamme, P
机构
[1] State Univ Ghent, Microbiol Lab, B-9000 Ghent, Belgium
[2] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2004年 / 40卷 / 03期
关键词
Stenotrophomonas maltophilia; identification; cystic fibrosis; gyrB restriction fragment length polymorphism;
D O I
10.1016/S0928-8244(03)00307-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Stenotrophomonas maltophilia isolates have been recovered from various clinical samples, including the respiratory tract of cystic fibrosis (CF) patients, but this organism is also widespread in nature. Previously it has been shown that there is a considerable genomic diversity within S. maltophilia. The aims of our study were to determine the taxonomic resolution of restriction fragment length polymorphism (RFLP) analysis of the polymerase chain reaction-amplified gyrB gene for the genus Stenotrophomonas. Subsequently, we wanted to use this technique to screen a set of S. maltophilia isolates (with emphasis on a specific subset, isolates recovered from CF patients), to assess the genomic diversity within this group. In this study we investigated 191 Stenotrophomonas sp. isolates (including 40 isolates recovered from CF patients) by means of gyrB RFLP. The taxonomic resolution of gyrB RFLP. and hence its potential as ail identification tool, was confirmed by comparison with results from published and novel DNA-DNA hybridisation experiments. Our data also indicate that the majority of CF isolates grouped in two clusters. This may indicate that isolates from specific genomic groups have an increased potential for colonisation of the respiratory tract of CF patients. (C) 2003 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:181 / 185
页数:5
相关论文
共 20 条
[11]   Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis [J].
Goss, CH ;
Otto, K ;
Aitken, ML ;
Rubenfeld, GD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (03) :356-361
[12]   Factors affecting the incidence Stenotrophomonas maltophilia isolation in cystic fibrosis [J].
Graff, GR ;
Burns, JL .
CHEST, 2002, 121 (06) :1754-1760
[13]   Genomic diversity of the genus Stenotrophomonas [J].
Hauben, L ;
Vauterin, L ;
Moore, ERB ;
Hoste, B ;
Swings, J .
INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1999, 49 :1749-1760
[14]   Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis [J].
Krzewinski, JW ;
Nguyen, CD ;
Foster, JM ;
Burns, JL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (10) :3597-3602
[15]  
Nakayama T, 1999, APPL ENVIRON MICROB, V65, P4334
[16]  
Talmaciu I, 2000, PEDIATR PULM, V30, P10, DOI 10.1002/1099-0496(200007)30:1<10::AID-PPUL3>3.0.CO
[17]  
2-Q
[18]   Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998 [J].
Valdezate, S ;
Vindel, A ;
Maiz, L ;
Baquero, F ;
Escobar, H ;
Cantón, R .
EMERGING INFECTIOUS DISEASES, 2001, 7 (01) :113-122
[19]  
Wolf A, 2002, INT J SYST EVOL MICR, V52, P1937, DOI [10.1099/ijs.0.02135-0, 10.1099/00207713-52-6-1937]
[20]  
[No title captured]